Stuart Duty - 15 Jul 2024 Form 3 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Reporting relationship
Director
Issuer ticker
MIST
Reported as of
15 Jul 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
17 Jul 2024, 16:15:04 UTC
Prior SEC filing
24 Jan 2024
Next SEC filing
29 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Minio, Attorney-in-Fact

Key filing fact

Stuart Duty filed Form 3 for Milestone Pharmaceuticals Inc. (MIST) on 17 Jul 2024.

Key facts

  • This page summarizes Stuart Duty's Form 3 filing for Milestone Pharmaceuticals Inc. (MIST).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jul 2024, 16:15.

Change

  • Previous filing in this sequence was filed on 24 Jan 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

SEC remarks

No securities beneficially owned.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .